"The company has said that it has been offered an equity finance facility, enabling the company to meet its new funding needs. We believe the details of the facility will be known within the next two weeks. It is likely the facility will involve monetizing future cash flows from MPC-150-IM."
Monetizing future cash flows? In other words giving a share of future cash flows from MPC-150-IM to another partner to fund the remaining CHF Trial? In other words a new partnership to be announced in 2 weeks? Celgene anyone? Someone tell me I'm wrong because that sounds too good to be true.
Lodge Partners - Article, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |